back to top
Friday, June 6, 2025

Lack of Key Mineral Induces Male Mice to Develop Ovaries

Share

A groundbreaking study led by researchers at Osaka University has revealed that iron deficiency in pregnant mice can disrupt the genetic machinery responsible for male sex determination, resulting in XY offspring developing ovaries—or even a combination of ovarian and testicular tissue. This finding, published in Nature, challenges the long‐held assumption that sex in mammals is dictated solely by chromosomal identity, underscoring the critical interplay between genetics and environmental factors during early embryonic development.

Understanding Mammalian Sex Determination
Sex determination in mammals traditionally hinges on the presence or absence of the Sry gene, located on the Y chromosome. In normal XY embryos, Sry is activated during a narrow window of gonadal development, prompting precursor cells in the bipotential gonad to differentiate into Sertoli cells and subsequently form testes. In XX embryos—lacking Sry—the default pathway leads to ovarian development. The newly published research reveals that the enzyme KDM3A, a histone demethylase, is essential for Sry activation. Crucially, KDM3A relies on dietary iron to perform its function: without sufficient iron, the enzyme cannot effectively demethylate histones and permit Sry expression.

Link Between Iron and KDM3A Function
KDM3A removes methyl groups from histone proteins at the Sry promoter region, facilitating access by transcriptional machinery. Iron serves as a cofactor for KDM3A’s catalytic activity; thus, when maternal iron levels drop below a critical threshold during gestation, KDM3A’s demethylase function falters. As a result, Sry remains silent, even in XY embryos, causing them to default to ovarian differentiation. Prior to this study, anecdotal evidence suggested that extreme environmental stresses might influence sex ratios or gonadal morphology, but few experiments had pinpointed a specific molecular pathway linking nutrient deficiency to sex reversal.

Experimental Design: Two Complementary Approaches
Researchers at Osaka University conducted two parallel experiments to test the hypothesis that iron deficiency during the critical window of gonadal sex determination disrupts male differentiation. In both experiments, pregnant mice were manipulated to create varying degrees of iron depletion.

Experiment 1: Acute Iron Removal via Chelating Agent
In the first experiment, eight‐week‐old female mice received injections of deferoxamine—a well‐known iron‐chelating drug—beginning two days before the estimated onset of embryonic sex determination and continuing for three days thereafter. This five‐day regimen coincides with embryonic days 10.5 to 12.5 in mice, the period during which Sry expression peaks in the primordial gonad. A control group of pregnant mice received saline injections.

At birth, pups were genotyped to identify chromosomal sex. Of the 72 XY pups born to iron‐depleted mothers, four (5.6 percent) displayed complete ovarian morphology, with bilateral ovaries and no evidence of testicular tissue. One additional XY pup exhibited ovotestis—having one ovary and one testis. By contrast, none of the XY pups born to control‐treated mothers showed any evidence of gonadal sex reversal. The small but significant number of XY mice with female or intersex gonads confirmed that acute maternal iron depletion alone can override chromosomal determinants.

Experiment 2: Chronic Low‐Iron Diet Combined with KDM3A Mutation
The second experiment sought to examine whether a more gradual, dietary model of iron deficiency could produce similar effects and to investigate the interplay between iron availability and KDM3A’s genetic function. In this arm, eight‐week‐old female mice were placed on a low‐iron diet (approximately 5 parts per million iron content, compared to 35 parts per million in standard rodent chow) for four weeks prior to mating. Dietary restriction continued up to six weeks after mating, ensuring that maternal iron stores remained depleted through the critical window of sex determination.

A subset of these low‐iron–fed females carried heterozygous loss‐of‐function mutations in the Kdm3a gene, rendering one allele inoperative. Offspring from these matings were genotyped for both chromosomal sex and Kdm3a mutation status. Among 43 XY pups with heterozygous Kdm3a mutation born to low‐iron–fed dams, two (4.7 percent) developed ovaries. In XY pups with homozygous wild‐type Kdm3a, even under low‐iron conditions, no sex reversal was observed. Furthermore, XY pups with the Kdm3a mutation born to mothers on normal iron diets displayed normal testis development.

These results illustrate a two‐fold requirement for disrupting male differentiation: reduced iron availability and compromised Kdm3a function. In other words, iron depletion alone can induce sex reversal in a small subset of XY embryos, but the effect is magnified when KDM3A activity is partially impaired, solidifying the enzyme’s central role in mediating Sry activation.

Quantifying the Incidence and Statistical Considerations
Although only a minority of XY offspring displayed gonadal sex reversal—approximately 5–6 percent in both experimental arms—the researchers emphasize that the effect is reproducible across two different models of iron deficiency. Statistical analysis using Fisher’s exact test confirmed that the frequency of XY individuals developing ovaries under iron‐depleted conditions was significantly higher than zero in each experiment (p < 0.01). Nevertheless, the low absolute numbers counsel caution in extrapolating to broader biological significance: for every 100 males conceived under such conditions, only around five or six would be expected to undergo complete sex reversal.

Lead author Dr. Yuki Nakamura states, “The relatively small percentage of affected pups underscores that other compensatory mechanisms may exist to protect critical developmental pathways. However, identifying that any XY embryo can develop ovaries purely due to dietary iron deficiency challenges the deterministic view of sex determination and highlights an unanticipated vulnerability in the system.”

Mechanistic Insights: KDM3A’s Role in Histone Demethylation
At the biochemical level, KDM3A belongs to the Jumonji C (JmjC) family of histone demethylases, which require Fe(II) and α‐ketoglutarate as cofactors. In XY embryos, KDM3A targets dimethylated lysine 9 on histone H3 (H3K9me2) at the Sry gene promoter. Removal of these repressive methyl marks permits the binding of transcription factors such as SF1 (steroidogenic factor 1) and SOX9, initiating the cascade that leads to Sertoli cell differentiation and testis cord formation. Under conditions of iron deficiency, KDM3A’s catalytic center cannot bind Fe(II), stalling demethylation and leaving H3K9me2 intact—thereby repressing Sry. The result is that the bipotential gonad follows the default ovarian pathway, even in the presence of a Y chromosome.

Implications for Broader Mammalian Development
Although this research focuses on mice, the authors highlight potential implications for other mammals, including humans. Approximately 20 percent of pregnant women worldwide experience iron deficiency anemia, particularly in resource‐limited settings. If similar mechanisms operate in humans, an expectation would be that severe iron deficiency during early pregnancy could influence gonadal differentiation in XY embryos. However, critical differences between species—such as timing of Sry expression and maternal–fetal iron transport mechanisms—mean that direct extrapolation requires caution.

Dr. Naomi Watanabe, a developmental biologist at Kyoto University unaffiliated with the study, cautions, “While the mouse model provides a powerful proof of principle, human embryonic development involves additional layers of regulation. Nonetheless, these findings underscore the importance of adequate maternal nutrition. If even a small percentage of human XY embryos were susceptible to sex reversal under extreme conditions, it would have profound implications for public health in areas where iron deficiency during pregnancy is endemic.”

Clinical Relevance and Future Directions
Given the study’s small incidence rates, researchers emphasize that it remains unclear whether similar effects occur in humans. Nevertheless, the identification of a dietary nutrient—iron—as a modulator of sex determination opens new avenues for investigating disorders of sex development (DSDs). Up to 1 in 4,500 live births in humans present with ambiguous genitalia or gonadal dysgenesis. While many DSDs are attributed to genetic mutations (for example, in SRY, SOX9, WT1), environmental cofactors have been underexplored.

The Osaka team plans to extend their research by:

  • Examining Dose–Response Relationships: By titrating maternal iron levels more finely, they aim to map the threshold below which KDM3A function fails. This could clarify whether partial iron deficiency—akin to mild anemia—poses any meaningful risk.
  • Exploring Other Tissues Affected by KDM3A: KDM3A regulates expression of numerous genes beyond Sry. The researchers will investigate whether iron depletion alters skeletal muscle development, adipogenesis or neuronal differentiation via KDM3A‐dependent pathways.
  • Translational Studies in Other Mammals: Preliminary experiments in rats and rabbits are underway to determine whether rodent‐specific findings hold in species with distinct gestational timelines.

“Our next step is to determine how generalizable this phenomenon is across mammalian orders,” says Dr. Nakamura. “If we can show that iron deprivation during a critical window affects sex determination in other species, it will strengthen the case for reexamining maternal nutrition guidelines globally.”

Expert Commentary: Ethical and Evolutionary Considerations
Beyond developmental biology, this study raises ethical and evolutionary questions. If environmental insults can override genetic sex determination, to what extent should public health policies account for such possibilities? In human populations where iron deficiency is commonplace, might undiagnosed XX males or XY females exist at higher frequencies than realized? While current genetic screening focuses on chromosomal karyotyping and gene‐specific mutations, perhaps nutritional history and maternal health should also form part of prenatal risk assessments.

Evolutionary biologist Dr. Samuel Greene of the University of Melbourne reflects, “Sex determination mechanisms evolved to be robust, yet this research suggests an Achilles’ heel under extreme nutritional stress. From an evolutionary perspective, such plasticity might have conferred survival advantages in times of famine, allowing populations to skew sex ratios adaptively. But in modern contexts, the stakes are not about natural selection—they concern individual health and societal readiness to support intersex or DSD individuals.”

Human Health Implications: A Cautious Outlook
Although extrapolating mouse findings to humans remains speculative, the researchers caution that severe maternal iron deficiency is already known to cause adverse outcomes—preterm birth, low birth weight and impaired neurodevelopment. Accordingly, obstetric guidelines worldwide already recommend screening and supplementation for pregnant women. Yet, if iron status also influences gonadal differentiation, it reinforces the need for vigilant prenatal care.

Obstetrician‐gynecologist Dr. Priya Desai, who practices in rural India, comments, “We’ve long known that iron deficiency affects maternal and fetal health broadly. This new evidence suggests that consequences may extend even to deviations in sex development—although human data are lacking. Nonetheless, it exemplifies why we must continue education and supplementation programs. Iron deficiency is preventable, and its elimination may remove any lingering risk, however small, of disrupted gonadal development.”

Public Reaction and Scientific Reception
Since the Nature publication, the paper has generated considerable interest within scientific circles. Online forums for developmental biology have buzzed with debate regarding the interplay between epigenetics and environmental cues. Some researchers question whether other micronutrients—zinc, folate, vitamin A—might similarly influence critical developmental genes via histone‐modifying enzymes.

In an interview on Nature’s podcast, reporter Rachel Fieldhouse noted, “The researchers weren’t surprised by the link between iron and KDM3A, given that many histone demethylases are metalloenzymes. What’s exciting is that this is among the first concrete demonstrations of an environmental factor—dietary iron—directly governing sex organ differentiation. Now, the field wants to see if other epigenetic regulators respond to nutrient availability during embryogenesis.”

READ MORE: Physicists Close in on New Physics Clues: How Antimatter, Supercomputers and Giant Magnets Resolved a 20-Year-Old Mystery

Social media reactions have been largely positive among science enthusiasts, although some outlets sensationalized the findings with headlines questioning whether human “gender” could be manipulated by diet—oversimplifying a complex biological process. Experts emphasize that the study does not imply pregnant women can choose their child’s sex by altering iron intake; rather, it reveals a previously unrecognized vulnerability that emerges only under severe deficiency.

Summary of Key Findings and Takeaways

  1. Iron‐Dependent Enzyme KDM3A Is Critical for Male Sex Determination: In XY mouse embryos, KDM3A demethylates histones at the Sry promoter, enabling transcription. Iron deficiency inhibits KDM3A activity, blocking Sry expression.
  2. Acute and Chronic Iron Depletion Can Induce Sex Reversal: Both short‐term chelation during the sex‐determination window and sustained low‐iron diet combined with partial Kdm3a loss‐of‐function produce ovaries or ovotestes in a small percentage (5–6 percent) of XY mice.
  3. Small but Significant Incidence Rates: Although the proportion of affected XY pups is low, the reproducibility across two experimental paradigms confirms that iron availability can override chromosomal sex cues.
  4. Potential Implications for Humans Remain Unclear: Human embryonic sex determination differs in timing and perhaps redundancy of epigenetic regulators. Nonetheless, the study highlights maternal nutrition as a factor warranting further investigation in disorders of sex development.
  5. Broader Relevance to Developmental Biology: The findings prompt new lines of inquiry into how other nutrient‐dependent enzymes (e.g., other JmjC demethylases, TET family DNA demethylases) influence gene regulation during critical windows of organogenesis.

Future Directions in Research and Clinical Practice
As the field moves forward, researchers will need to:

  • Conduct human epidemiological studies correlating maternal iron status with rates of DSDs, while controlling for known genetic mutations.
  • Investigate whether controlled iron supplementation during early pregnancy reduces the occurrence of intersex conditions in at‐risk populations.
  • Explore additional histone modifiers (e.g., KDM4, KDM5 families) whose activity depends on cofactors such as Fe(II), α‐ketoglutarate or ascorbate, to determine if other gene networks respond similarly to nutrient levels.

Clinicians, for their part, may adopt more stringent screening protocols, especially in regions where iron deficiency anemia remains prevalent. Genetic counselors might begin incorporating nutritional history into risk assessments for families with a history of sex development disorders.

Conclusion: Rethinking Sex Determination as a Gene–Environment Collaboration
The Osaka University study disrupts the binary notion of chromosomal sex determination by showing that, under conditions of maternal iron deficiency, XY embryos can develop ovaries or ovotestes. Through two carefully designed experiments, the researchers demonstrated that KDM3A’s iron‐dependent demethylase activity is indispensable for activating Sry during a narrow embryonic window. When iron is scarce, KDM3A cannot function, and the embryo defaults to ovarian development.

Although these findings arise from a mouse model and affect a small percentage of XY offspring, they open a novel research frontier at the intersection of epigenetics, developmental biology and maternal nutrition. As the global community strives to reduce micronutrient deficiencies, understanding how environmental factors shape fundamental processes like sex determination may inform preventive strategies and refine prenatal care. In the meantime, this study serves as a potent reminder: even the most “hardwired” biological programs are vulnerable to the nutritional environment that supports them.

Read more

Local News